We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-4.50 | -0.28% | 1,600.00 | 1,598.00 | 1,599.00 | 1,613.00 | 1,589.00 | 1,613.00 | 3,788,149 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.35 | 65.81B |
Date | Subject | Author | Discuss |
---|---|---|---|
11/7/2023 20:08 | NHS to offer Shingrix to over 65s from Sept: | zho | |
11/7/2023 13:30 | But why on earth are you here then? Stop trying to save us from ourselves. | supermarky | |
11/7/2023 11:50 | Back in 1307 | panache1 | |
11/7/2023 10:24 | Can only hope so good news end of July or a bid for the company looks cheap | mj19 | |
11/7/2023 08:12 | SAN DIEGO--(BUSINESS WIRE)--Elsie Biotechnologies, Inc., a biopharmaceutical company unlocking the full potential of oligonucleotide therapeutics, announced today a research collaboration agreement with GSK plc (LSE/NYSE: GSK) to advance the discovery and development of Elsie’s innovative oligonucleotide discovery platform with the aim of finding novel oligonucleotides optimized for safety, efficacy, and delivery. The collaboration combines GSK's extensive expertise in DNA encoded library technologies with Elsie's drug discovery platform. The companies will begin an initial research period where GSK and Elsie will explore the platform capabilities. Throughout the research term, GSK may exercise an option to a non-exclusive license from Elsie for the discovery platform and P(V) chemistry technologies to employ in GSK’s own oligonucleotide drug discovery research. | tradermichael | |
10/7/2023 16:25 | Down down down! | abdullla | |
10/7/2023 10:53 | UK regulator authorizes GSK's RSV vaccine Britain's medicines regulator authorized GSK's vaccine for respiratory syncytial virus (RSV) for older adults, the drugmaker said on Monday. | geckotheglorious | |
10/7/2023 10:10 | For all you income boys who want a monthly dividend just worked out.BATS, GSK, Unilever 3 shares all you need.Money coming in every month. | montyhedge | |
10/7/2023 06:58 | yep, I wonder how long before the Pfizer dam bursts? | jonjoneil | |
09/7/2023 20:22 | Compensation compensation compensation flood gate opening up | covid 19 deal | |
09/7/2023 18:32 | I don’t know last paragraph talked about a search for a new CEO. | berny3 | |
09/7/2023 13:19 | Just read it - nothing new | jonjoneil | |
09/7/2023 09:30 | Is it worth reading- anything new? | berny3 | |
09/7/2023 07:42 | Big article today in the Business section, pages 2 and 3 of the Sunday Times on GSK and Walmsley | panache1 | |
08/7/2023 11:11 | Alphorn - Miridesap | toffeeman | |
07/7/2023 21:43 | Pharma stocks fall after Alzheimer’s drug (Biogen) receives warning label (FT). Not sure why any read across to GSK. Perhaps more in the weekend press. Maybe lack of good news on AZN's lung cancer drug trials too this week? New disease targets are becoming more and more difficult to tackle. | alphorn | |
07/7/2023 16:28 | Not good now! Stuck and holding | mj19 | |
07/7/2023 10:06 | What's the dividend around 5%, if it is might as well put your money in a BS earning 5.5% no risk, GSK shareprice below what it was 30 years ago. So no no growth in shareprice awful performance. | montyhedge | |
06/7/2023 17:05 | Yep we now have to fund a 100% GDP public Debt ratio, thanks to the Covid largesse. Interest rates aren't going down any time soon, the Market will set the punishment interest rate for Tory squandering on furlough and the leftist nonsense of lockdown, which in the long run will kill more people than it saved. But heck, we always want action today without considering the long term consequences like living standards, suicides, business failures etc. If we get anywhere near 7% for risk free FSCA protected Bonds ( whence money doubles every ten year) it will be absolute curtains for UK Equities. You can get about 6.25% fixed as we speak. | stewart64 | |
06/7/2023 10:51 | What’s the point of owning dross like this with a 4.5 pc yield, zero growth, dire management and listed on the worst performing major exchange in the world. You will soon have 6pc yield on U.K. treasuries, risk free. Most of ftse now pointless, has been for a while really. | porsche1945 | |
06/7/2023 10:02 | I'm keen to buy more...but at what price? That is the Q !! Answers on a post card pls ! | panache1 | |
05/7/2023 21:26 | GSK shareprice below what it was 30 years ago. Astra ahead, something not right. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions